The PrEP for Pregnant and Breastfeeding Women Toolkit is designed for use by policy makers, program implementers, and healthcare workers to expand provision of PrEP to PBFW. The evidence-informed materials are designed to be adapted to reflect local context and priorities, national policy and guidelines, and implementation context surrounding provision of PrEP to PBFW.
A study comparing the characteristics and outcomes of adolescents living with perinatally acquired HIV (ALPH) Using data from 15 International epidemiology Databases to Evaluate AIDS in Southern Africa sites.
The 16 Days of Activism Against Gender-Based Violence against women is an international campaign from November 25-December 10. Read more about the campaign's goals and where to access additional resources and support.
The HIV Prevention Trials Network study (HPTN 084) on the safety and efficacy of the long-acting injectable antiretroviral drug cabotegravir (CAB LA), for pre-exposure prophylaxis (PrEP) in HIV-uninfected women, was stopped early by the trial Data and Safety Monitoring Board (DSMB) as results showed CAB LA to be highly effective in preventing HIV acquisition.
An inclusive summit for multidisciplinary experts working with adolescents affected by HIV, which will be held as a series of virtual workshops throughout the month of November. Topics will include youth leadership, mental health and psychosocial support interventions, participatory research approaches, and Mhealth and new technologies, among others.